WallStreetZenWallStreetZen

NASDAQ: INVA
Innoviva Inc Earnings & Revenue

INVA past earnings growth

How has INVA's earnings growth performed historically?
Company
-81.29%
Industry
53.5%
Market
104.04%
INVA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
INVA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
INVA's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

INVA past revenue growth

How has INVA's revenue growth performed historically?
Company
-22.18%
Industry
182.01%
Market
17.81%
INVA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INVA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INVA's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

INVA earnings and revenue history

Current Revenue
$290.4M
Current Earnings
$49.9M
Current Profit Margin
17.2%

INVA Return on Equity

Current Company
8.6%
Current Industry
15.4%
Current Market
-8.4%
INVA's Return on Equity (8.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when INVA announces earnings.

INVA Return on Assets

Current Company
4.3%
Current Industry
2.2%
INVA is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

INVA Return on Capital Employed

Current Company
7.42%
Current Industry
17.7%
INVA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INVA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
INVA$290.43M$118.16M$49.88M+2.99%-15.13%
VRDN$347.00k-$215.04M-$216.66M-47.97%N/A
ARCT$296.24M$94.16M$99.33M+84.80%N/A
PLRX$3.55M-$149.29M-$155.29M-98.73%N/A
IMNM$10.19M-$21.23M-$21.96MN/AN/A

Innoviva Earnings & Revenue FAQ

What were INVA's earnings last quarter?

On Invalid Date, Innoviva (NASDAQ: INVA) reported Q3 2023 earnings per share (EPS) of $1.26, up 66.93% year over year. Total Innoviva earnings for the quarter were $82.05 million. In the same quarter last year, Innoviva's earnings per share (EPS) was $3.81.

If you're new to stock investing, here's how to buy Innoviva stock.

What was INVA's earnings growth in the past year?

As of Q1 2024, Innoviva's earnings has grown -81.29% year over year. This is 134.8 percentage points lower than the US Biotechnology industry earnings growth rate of 53.5%. Innoviva's earnings in the past year totalled $49.88 million.

What was INVA's revenue last quarter?

On Invalid Date, Innoviva (NASDAQ: INVA) reported Q3 2023 revenue of $67.26 million up 0% year over year. In the same quarter last year, Innoviva's revenue was $67.26 million.

What was INVA's revenue growth in the past year?

As of Q1 2024, Innoviva's revenue has grown -22.18% year over year. This is 204.19 percentage points lower than the US Biotechnology industry revenue growth rate of 182.01%. Innoviva's revenue in the past year totalled $290.43 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.